financetom
Business
financetom
/
Business
/
SBI's Dinesh Kumar Khara: No more planned divestments this year after card subsidiary IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SBI's Dinesh Kumar Khara: No more planned divestments this year after card subsidiary IPO
Nov 28, 2019 2:19 AM

State Bank of India’s (SBI) cards business will soon be tapping the primary market with an initial public offering (IPO). Dinesh Kumar Khara, managing director and group executive — associates and subsidiaries at SBI, shared his views on the developments in an interview with CNBC-TV18.

On the valuation, he said: “We have filed the draft red herring prospectus (DRHP) and after that I am under certain obligations not to indicate any kind of a valuation. We will have to wait and watch because much of it will depend upon how the market is at the material point of time, so after the DRHP seen by the potential investors and we will carry out the road show perhaps we will have some sense. But it is too early for us to comment anything on the valuation.”

Revenue and earnings before interest, taxes, depreciation, and amortization (Ebitda) for the cards business has been quite healthy, he added.

“We are a long-term player as far as SBI Cards is concerned and we will stay on that is for sure and as far as the current offer for sale is concerned, we are offloading 4 percent and Carlyle

When asked if SBI will be considering chipping off its stake a little more, he replied: “As of now, as of now we don't have any such plan because it is business which is very complementary too SBI's primary activity so as of now we have no such plan further for the further offloading.”

On monetizing SBI’s general insurance business, Khara said: “As far as this financial year is concerned, we don't have anything else planned. Maybe in the coming financial year as I was indicating that all these decisions also are a function of the market so we will have to see how the market is. And hopefully by that time will take stock of the situation and then we will take a call.”

On growth prospects of the cards business, he said: “Eventually when the entities are growing, at some stage we will have to introduce them to the market. So that there should have any constraints for their growth going forward. So, when an entity grow beyond a particular size, it is always advisable that they should be in a position to tap the public markets.”

On capital raising plans, Khara said: “Actually we are quite comfortable we have raised 81

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Magnite Insider Sold Shares Worth $722,867, According to a Recent SEC Filing
Magnite Insider Sold Shares Worth $722,867, According to a Recent SEC Filing
Jun 20, 2025
04:35 PM EDT, 06/20/2025 (MT Newswires) -- David Day, CFO, on June 18, 2025, sold 38,146 shares in Magnite ( MGNI ) for $722,867. Following the Form 4 filing with the SEC, Day has control over a total of 443,528 common shares of the company, with 443,528 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1595974/000141588925017858/xslF345X05/form4-06202025_080628.xml ...
Magnite Insider Sold Shares Worth $2,572,991, According to a Recent SEC Filing
Magnite Insider Sold Shares Worth $2,572,991, According to a Recent SEC Filing
Jun 20, 2025
04:34 PM EDT, 06/20/2025 (MT Newswires) -- James Rossman, Director, on June 18, 2025, sold 137,007 shares in Magnite ( MGNI ) for $2,572,991. Following the Form 4 filing with the SEC, Rossman has control over a total of 93,679 common shares of the company, with 93,679 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1595974/000141588925017863/xslF345X05/form4-06202025_080622.xml ...
Pharmala Biotech Files for $50 Million in Potential Securities Offerings
Pharmala Biotech Files for $50 Million in Potential Securities Offerings
Jun 20, 2025
04:34 PM EDT, 06/20/2025 (MT Newswires) -- Pharmala Biotech ( MDXXF ) after trade Friday said it filed a preliminary base shelf prospectus with Canadian securities regulators. This filing gives the company flexibility to raise up to $50 million through various types of securities, such as shares, warrants, or debt, over the next 25 months, if market conditions are favorable,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved